Institutions sold more Singapore shares than they bought in early November, but a handful of companies were on the other side of the trade.
Over the five sessions to 5 November 2026, institutions recorded net outflows of S$140.9 million, while 19 primary-listed companies bought back shares worth S$11.1 million.
United Overseas Bank (SGX: U11), Seatrium (SGX: 5E2) and The Hour Glass (SGX: AGS) were the biggest buyers, but three smaller names from the iEdge Singapore Next 50 Index were also buying.
Raffles Medical Group (SGX: BSL), Pan-United Corporation (SGX: P52) and UltraGreen.ai (SGX: ULG) spent a combined S$1.47 million to repurchase 1.75 million shares, accounting for about 13% of the week’s total buyback value.
Share buybacks by three iEdge Singapore Next 50 stocks (30 October to 5 November 2026)
| Company | Shares Repurchased | Total Buyback Value | Average Price |
|---|---|---|---|
| Raffles Medical Group | 1,400,000 | S$1,185,549 | S$0.85 |
| Pan-United Corporation | 100,000 | S$158,240 | S$1.58 |
| UltraGreen.ai* | 250,000 | S$127,421 | S$0.51 |
| Total | 1,750,000 | S$1,471,210 | – |
Source: SGX. Buyback value includes stamp duties and clearing charges. Average price as reported by SGX. Totals calculated by The Smart Investor. *Value shown in Singapore dollars as reported by SGX.
The size of a buyback only tells you so much; you also want to know whether free cash flow can fund it.
Can Raffles Medical afford its buybacks while profit falls?
Raffles Medical Group, or RMG, is an integrated healthcare provider operating across Singapore, Greater China, Vietnam, Cambodia and Japan.
Its S$1.19 million buyback ranked fourth among the 19 companies that bought back shares that week.
Its latest results were softer, with revenue for the first half of 2026 (1H2026) slipping 6.7% year on year (YoY) to S$353.2 million.
Profit attributable to shareholders fell 9.6% YoY to S$29.0 million, weighed down by lower occupancy at its transitional care facilities and a 52.3% drop in finance income.
Cash flow, however, moved in the opposite direction, with RMG generating S$61.3 million of free cash flow (operating cash flow minus capital spending) in 1H2026, up 17.9% YoY.
It also repaid S$51.1 million of loans during the half and held S$262.3 million in cash with no bank borrowings as at 30 June 2026.
RMG did not declare an interim dividend, in line with its practice since FY2021 of paying a single annual core dividend.
Its FY2025 final dividend of S$0.030, paid on 22 May 2026, was 20% higher than the S$0.025 paid a year earlier.
Can Pan-United’s cash flow keep pace with its profit growth?
Pan-United Corporation, or PUC, is Singapore’s largest ready-mix concrete supplier and bought back 100,000 shares for S$158,240 during the week.
Construction demand lifted its results, with 1H2026 revenue climbing 37% YoY to S$549.6 million and net profit attributable to shareholders rising 49% YoY to S$30.6 million.
PUC also raised its interim dividend by 50% to S$0.015, from S$0.010 a year earlier.
Cash flow was more modest, with free cash flow coming in at S$7.4 million, up from S$1.0 million a year earlier.
A S$26.0 million increase in trade and other receivables tied up cash as revenue grew.
As at 30 June 2026, PUC held S$86.2 million in cash against S$21.0 million of borrowings, excluding lease liabilities.
Demand looks set to hold, with S$31 billion of the S$47 billion to S$53 billion in construction demand forecast by the Building and Construction Authority for 2026 already awarded as at June 2026.
Management also flagged energy cost fluctuations and supply chain disruptions as ongoing challenges.
Why is UltraGreen.ai buying back shares as its guidance falls?
UltraGreen.ai is a Singapore-headquartered provider of fluorescence-guided surgery solutions, with indocyanine green (ICG) as its flagship product.
The company bought back 250,000 shares for S$127,421 on 3 November 2026, while SGX separately reported that chief executive Ravinder Sajwan bought 250,000 shares on-market the next day.
For the nine months ended 30 September 2026 (9M2026), revenue from continuing operations rose 35% YoY to US$131.8 million.
US revenue climbed 35% to US$101.3 million, while Rest of World revenue grew 36% to US$30.5 million.
The US market has become tougher, with rival ICG products from Zydus Lifesciences and Provepharm entering the market, creating pricing pressure and changing how customers buy.
UltraGreen.ai now expects FY2026 revenue to fall below its earlier guidance of US$175 million to US$185 million, although it has not provided a revised figure.
Management also expects the US business to remain under pressure in FY2027.
The company has room to act, with US$214 million in cash and short-term investments and no borrowings as at 30 September 2026.
The company has also proposed a share buyback programme of up to US$30 million and a target of paying out at least 30% of net profit, excluding exceptional items, as dividends each year.
Dividends would be paid twice a year, subject to board approval.
UltraGreen.ai has applied for a tax exemption that, if approved, would reverse a one-off US$8.5 million tax provision booked in FY2025.
Investors should strip out any such boost when assessing future profit.
Get Smart: Ask what pays for the buyback
A buyback during a week of institutional selling can look like a vote of confidence, but the better test is whether free cash flow can fund it alongside the dividend.
RMG’s 1H2026 free cash flow and cash reserves give it plenty of room.
On the other hand, PUC’s S$7.4 million of free cash flow fell well short of the S$24.5 million it paid in dividends in 1H2026, making its receivables worth watching in the second half.
For UltraGreen.ai, the key question is how much the growing US competition will eat into the profit supporting its dividend target.
Check the next set of cash flow numbers before reading too much into any buyback.
Imagine owning businesses that continued paying shareholders even when markets were falling. That’s the appeal of dividend investing done well. Our FREE report reveals 6 SGX companies that paid dividends every single year for two decades, through the Global Financial Crisis, COVID-19, and 2022’s rate shock. Start building the kind of income stream that could fund a more comfortable retirement. Get your free report here.
Follow us on Facebook, Instagram, Telegram and YouTube for the latest investing news and analyses!
Disclosure: The Smart Investor owns shares in RMG and The Hour Glass.



